Akinetic Mutism Induced by Tacrolimus

Clinical Neuropharmacology

Volumn 32, Issue 5, 2009, Pages 293-294

  Sierra Hidalgo, Fernando ^a   Martínez Salio, Antonio ^a   Moreno García, Sara ^a   De Pablo Fernández, Eduardo ^a   Correas Callero, Elisa ^a   Ruiz Morales, Juan ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Akinetic mutism; Immunosuppressive agents; Neurotoxicity; Tacrolimus

Indexed keywords

CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

AGED; AKINESIA; AKINETIC MUTISM; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONFUSION; DELIRIUM; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG INTOXICATION; DRUG SENSITIVITY; DRUG WITHDRAWAL; HUMAN; HYPOREFLEXIA; LIVER TRANSPLANTATION; MALE; MUSCLE RIGIDITY; NEUROTOXICITY; PRIORITY JOURNAL; SYMPTOM; TREMOR; VISUAL HALLUCINATION;

AGED; AKINETIC MUTISM; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; TACROLIMUS;

EID: 70349814396     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181a77fab     Document Type: Article

References (13)

1. Wijdicks EF, Cranford RE. Clinical diagnosis of prolonged states of impaired consciousness in adults. Mayo Clin Proc 2005;80:1037-1046.
2. Ropper AH, Brown RH. Coma and related disorders of consciousness. Adams and Victor's. Principles of Neurology. 8th ed. New York, NY: McGraw-Hill; 2005:302-321.
3. Posner JB, Saper CB, Schiff ND, et al. Prognosis in coma and related disorders of consciousness, mechanisms underlying outcomes, and ethical considerations. Plum and Posner's. Diagnosis of Stupor and Coma. 4th ed. New York, NY: Oxford; 2007:341-385.
4. Choudhari KA. Subarachnoid haemorrhage and akinetic mutism. Br J Neurosurg 2004;18:253-258.
5. Wijdicks EF, Weisner RH, Dahlke LJ, et al. FK506-induced neurotoxicity in liver transplantation. Ann Neurol 1994;35:498-501.
6. Mueller AR, Platz KP, Bechstein WO, et al. Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation 1994;58:155-170.
7. Bechstein WO. Neurotoxicity of calcineurin inhibitors:Impact and clinical management. Transpl Int 2000;13:313-326.
8. Wijdicks EF. Neurotoxicity of immunosuppressive drugs. Liver Transpl 2001;7:937-942.
9. Boeve BF, Kimmel DW, Aronson AE, et al. Dysarthria and apraxia of speech associated with FK-506 (tacrolimus). Mayo Clin Proc 1996;71:969-972.
10. Bronster DJ, Gurkan A, Buchsbaum MS, et al. Tacrolimus-associated mutism after orthotopic liver transplantation. Transplantation 2000;70:979-982.
11. Sokol DK, Molleston JP, Filo RS, et al. Tacrolimus (FK506)-induced mutism after liver transplant. Pediatr Neurol 2003;28:156-158.
12. Ahn KJ, Lee JW, Hahn ST, et al. Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity. Br J Radiol 2003;76:916-919.
13. Emre S, Genyk Y, Schluger LK, et al. Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients. Transpl Int 2000;13:73-78.